Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 25, 2026.

Leukocyte Tyrosine Kinase Functions in Pigment Cell Development

Susana S. Lopes, Xueyan Yang, Jeanette Müller and 11 more (opens in a new tab)

PLoS Genetics · 2008

doi:10.1371/journal.pgen.1000026 (opens in a new tab)

Abstract

A fundamental problem in developmental biology concerns how multipotent precursors choose specific fates. Neural crest cells (NCCs) are multipotent, yet the mechanisms driving specific fate choices remain incompletely understood. Sox10 is required for specification of neural cells and melanocytes from NCCs. Like sox10 mutants, zebrafish shady mutants lack iridophores; we have proposed that sox10 and shady are required for iridophore specification from NCCs. We show using diverse approaches that shady encodes zebrafish leukocyte tyrosine kinase (Ltk). Cell transplantation studies show that Ltk acts cell-autonomously within the iridophore lineage. Consistent with this, ltk is expressed in a subset of NCCs, before becoming restricted to the iridophore lineage. Marker analysis reveals a primary defect in iridophore specification in ltk mutants. We saw no evidence for a fate-shift of neural crest cells into other pigment cell fates and some NCCs were subsequently lost by apoptosis. These features are also characteristic of the neural crest cell phenotype in sox10 mutants, leading us to examine iridophores in sox10 mutants. As expected, sox10 mutants largely lacked iridophore markers at late stages. In addition, sox10 mutants unexpectedly showed more ltk-expressing cells than wild-type siblings. These cells remained in a premigratory position and expressed sox10 but not the earliest neural crest markers and may represent multipotent, but partially-restricted, progenitors. In summary, we have discovered a novel signalling pathway in NCC development and demonstrate fate specification of iridophores as the first identified role for Ltk.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 25, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Understanding mechanisms determining the selection of specific fate choices by multipotent precursors is of fundamental importance in developmental and stem cell biology. Neural crest cells (NCCs) are a favoured model for investigation of fate specification mechanisms, being multipotent precursors of diverse cell-types, including craniofacial cartilage, peripheral neuronal and glial cell-types and pigment cells. The mechanism driving specification of multipotent progenitors in the neural crest (NC) to fate-restricted cell types is controversial. Multipotent NC stem cells with broad potential have been isolated from embryos, even from post-migratory locations, leading to the hypothesis of direct fate restriction, whereby local signals instruct multipotent stem cells to adopt specific fates (reviewed in. In contrast, numerous studies indicating that NCCs include partially-restricted cells has suggested progressive fate restriction as an alternative model (reviewed in,). Thus, multipotent precursors gradually lose the potential to generate certain derivative cell-types, forming partially-restricted precursors before eventually becoming specified to an individual fate. The number and character of these intermediate precursors in vivo remains largely undefined.

The molecular mechanisms underlying fate restriction also remain poorly understood. Genetic analysis in mouse and zebrafish identifies key transcription factors required for specification of several or individual fates. Perhaps the best characterised example is that of Microphthalmia-related transcription Factor (Mitf), which is pivotal for melanocyte specification,,. Sox10 is required in multipotent NCCs to drive transcription of Mitf and other transcription factors (e.g.,,,,(reviewed in, while Pax3 acts synergistically with Sox10 to regulate the mouse Mitf promoter,.

Extracellular signals are also important in NCC fate specification. For example, Wnt signals are required for melanocyte specification via transcriptional activation of Mitf,,. Signalling by these pathways acts together with intrinsic factors such as Sox10 and Pax3 to induce specific cell-fates. Further signals remain to be identified and for some NC-derived fates, including other pigment cell-types, no fate specification factors have yet been identified. Surprisingly, even where key factors have been identified, in most cases the receptors mediating these signals are unknown.

Leukocyte tyrosine kinase (LTK) was first identified as an insulin receptor-like receptor tyrosine kinase (RTK) expressed in mouse haematopoietic cells. Within the insulin receptor superfamily, LTK is most closely-related to anaplastic lymphoma kinase (ALK). In mammals LTK's function remains unknown, although it is expressed in pre-B and B lymphocytes and in the adult brain,. It is widely expressed in human leukaemias and is a candidate locus contributing to the multigenic autoimmune disease, systemic lupus erythematosus (OMIM#152700).

Mutations in the zebrafish shady (shd) locus were identified in a large-scale mutagenesis screen. Iridophores, an iridescent pigment cell widespread in anamniotes, are reduced in number in shd mutants. Here we show that other NC derivatives are not affected in shd mutants. We demonstrate that shd encodes the zebrafish orthologue of LTK and functions cell-autonomously within the NC. We show that strong shd mutants lack iridoblast lineage markers, including ltk which is highly reduced from the very earliest stage in premigratory NCCs. Later some NCCs die by apoptosis, after failing to become specified to iridophore or other fates. Zebrafish sox10 (also known as colourless) mutants share the strong iridophore phenotype of shd mutants and show consistent defects in fate specification of non-ectomesenchymal NC derivatives,,,,. We have previously proposed that fate specification defects may underlie the sox10 mutant iridophore defect,. As expected, late iridophore markers are absent. At earlier stages ltk expression is detected in an increased number of cells compared with wild-type (WT) siblings. Our data indicates that these ltk-expressing cells are most likely partially-restricted precursors. Together, these observations identify the first loss of function mutants for this poorly characterised RTK and suggest that Ltk mediates iridophore fate specification from multipotent NCCs.

Shd mutants have reduced iridophores and form a broad allelic series

shd mutant embryonic phenotypes formed a clear allelic series; homozygotes for strong alleles (e.g. shdty82) have very few (<3) iridophores and die as larvae, those for weaker alleles (e.g. shdty9) show reduced numbers of differentiated iridophores in the embryo and are adult viable, but phenotypically normal (Figure 1A, 1B, 1D, 1E, 1G, 1H). In all cases, and in contrast to all iridophore mutant phenotypes identified before, remaining iridophores in shd mutants were invariably normally pigmented and hence appeared normally differentiated. Independent screens for adult pigment pattern mutants identified further mutants with reduced iridophores in the body and eyes (j9s1, j9e1 and j9e2). The most severe of these, j9s1, also lacked late stripe melanophores, and appeared similar to the roseb140 phenotype; SLJ unpublished)(Figure 1C, 1F, 1I). Mapping and complementation testing showed these to be allelic to shd (data not shown). These adult viable alleles had no detectable abnormal embryonic phenotype as homozygotes, although in transheterozygous combination with shdty82 they showed an embryonic iridophore phenotype of intermediate strength (data not shown); thus the adult viable alleles are also hypomorphic alleles.

Iridophores are derived from the NC. However, both of the other pigment cell-types, melanophores and xanthophores, as well as peripheral neuronal, glial and skeletogenic derivatives examined with specific markers showed comparable numbers and patterns in shd mutants and WT siblings (Figure S1). We conclude that the shd mutant phenotype is restricted within the NC to the iridophore lineage.

Shd acts cell-autonomously within the NC

We then used genetic chimaeras formed by transplanting WT cells, labelled with rhodamine and biotin-conjugated dextran beads, into shdty82 mutants to ask whether the shd iridophore phenotype resulted from cell-autonomous function within the NC. Of 291 host embryos receiving WT cells, 188 survived the procedure to 3 dpf and could be scored for iridophore phenotype. Of these, 40 embryos (21.2%) were identified as shd mutant hosts by the general absence of iridophores and 22 were chimaeric, containing some rhodamine fluorescent cells. Of these, seven embryos had iridophore counts above normal shdty82 mutant levels (Table S1). In these individuals, most or all iridophores exhibited biotin tracer and were derived from WT donor cells, consistent with cell-autonomous shd gene function (Figure S1I, S1L, and S1O). As expected, some, but importantly not all, of these embryos also had up to two unlabelled iridophores in the expected sites (dorsal stripe or lateral patch) for the occasional ‘escaper’ iridophores seen in shdty82 mutants. Thus, these studies demonstrated that shd acts cell-autonomously in iridophore lineage development.

Positional cloning identifies shd as encoding zebrafish leukocyte tyrosine kinase

In the absence of candidate genes, we utilised a positional cloning approach to identify shd. Linkage analysis mapped shd within 0.1 cM of marker z10985 on linkage group 17 (Figure 2A). Assuming average recombination frequencies, we reasoned that this marker likely lay within c. 70 kb of the shd gene and that both might be contained within the insert of a single genomic PAC. We isolated three PACs containing z10985 from the PAC706 library. Pulse field gel electrophoresis analysis of the PAC inserts defined an overlapping contig spanning 207.5 kb of genomic sequence (Figure 2B). Microinjection of PAC DNA into 1- or 2-cell stage zebrafish embryos demonstrated that PAC3, but not the others, partially rescued the shdty82 mutant iridophore phenotype (Figure 2C), indicating that PAC3 contained a functional shd gene. Analysis of the PAC contig sequence (Sanger Centre zebrafish genome project) using the NIX gene prediction package identified one gene fully contained within PAC3. This gene encodes an RTK, of the insulin receptor class and most similar to human ALK and LTK (Figure 2E).

Sequencing cDNAs for this ALK/LTK-like gene from AB WT embryos identified distinct isoforms generated by alternative splicing (Figure S2). BLAST searches identified closely-related RTKs from the zebrafish (XM_686872, XM_001342889 and XM_687805) and other vertebrates (Table S2) in the NCBI databases. We used multiple sequence alignments and phylogenetic estimation protocols to determine the likely relationships between our cDNAs and these genes (Figure 2H, Figure S3). Our phylogenetic analyses identified; i) the invertebrate genes as a clear outgroup to the vertebrate homologues; ii) zebrafish sequence XM_686872, on chromosome 17 but physically distant from shd, as the zebrafish ALK orthologue, which we name alk; iii) our cDNAs and XM_001342889 and XM_687805 as zebrafish Ltk sequences. These latter genes resolve in build 7 of the zebrafish genome (Zv7) to one locus, the zebrafish orthologue of LTK, which we name ltk. We note that while all mammalian Ltk proteins are predicted to lack MAM (meprin/A5/µ) domains, thought to mediate protein-protein interactions, the predicted chicken and zebrafish Ltk proteins, and all Alk proteins, possess them (Figure 2E).

These data strongly suggested that the shd mutations identified the ltk gene. Injection of WT embryos with a translation-blocking ltk morpholino oligonucleotide generated strong morphant phenocopies of shd mutants in a dose-dependent manner (Figure 2D; data not shown). Embryos injected with double doses (18.4 or 36.8 ng) of a 5 bp mismatch morpholino showed no phenotype (0/406 injected), whereas siblings injected with single doses (9.2 or 18.4 ng) of ltk morpholino showed a substantial proportion of embryos with a severe loss of iridophores (27/264 injected), as well as many with weaker phenocopies. The knockdown phenotype precisely phenocopied the shd mutant allelic series, supporting the conclusion that shd is ltk.

Confirmation that shd is ltk came from identification of ltk point mutations in three shd mutant alleles by sequencing the Ltk coding region from RNA extracted from shd homozygotes (Figure 2E, Figure S2). The shdty82 mutation 2356A>T (taking the A in the translation initiation codon as +1) results in a premature STOP codon, generating a truncated predicted protein lacking the tyrosine kinase domain, consistent with the strong mutant phenotype. This mutation fortuitously generates an RFLP allowing us to confirm that segregation of this mutation correlated perfectly with the embryonic phenotype (Figure 2F). shdj9e2 mutates a splice donor site, resulting in a transcript with an in-frame deletion of exon 26 encoding a variant of Ltk in which the tyrosine kinase domain activation loop is deleted (Figure 2G). It is likely that this variant protein will be less readily activated, consistent with the weak mutant phenotype. shdj9s1 mutation, 2275C>T, results in a P759S substitution in the extracellular region. This nucleotide change is the only difference between the shdj9s1 allele and the cDNA sequence for the WT C32 allele that the mutation was isolated on (data not shown). Moreover, this nucleotide change is not found on the 3 sequenced BACs or PACs, each derived from a different haplotype, that span this region, further supporting that the P759S substitution generates a mutant protein. Interestingly, this proline residue is conserved in chicken and mammalian LTKs, as well as in the LTK orthologue Drosophila Alk, but not in the corresponding tetrapod ALKs. Mutations affecting this residue in Drosophila Alk have not been reported to date.

Together, our data unambiguously identify shd as zebrafish ltk, showing that the shd mutant iridophore phenotype results from loss of Ltk signalling within the developing NC. This is the first time that a vertebrate Ltk loss of function phenotype has been defined.

shd expression is prominent in NCCs and iridophores

To clarify the role of ltk in iridophore development, we determined the spatiotemporal pattern of ltk gene expression by whole-mount mRNA in situ hybridisation (ISH). Our cell-autonomy studies predicted NC expression of ltk, but expression might be restricted to differentiated iridophores or be found at earlier stages in NC development. Here we focus on expression in NCCs and their derivatives, but we also saw ltk expression in notochord from 18–24 hpf (Figure 3A–3C) and prominently in brain and swim bladder from 3 dpf (data not shown).

From 48 hpf onwards, ltk-expressing cells formed a series of spots along the dorsal and ventral stripes, as well as on the eye, a pattern strikingly reminiscent of differentiated iridophores (Figure 1A and 1B, Figure 3J, 3O; 3XY and RNK, unpub. data). Consistent with this, the pattern was identical to that of ednrb1, the only characterised iridophore marker (Figure 3O, 3U, 3AA, and 3AE). To test definitively if iridophores express ltk, we photographed the dorsal stripe iridophore pattern of individual WT embryos at 72 hpf, processed the embryos for ltk expression and then photographed the ltk pattern; ltk-expressing cells (Figure 3J) and differentiated iridophores (Figure 3E) showed an excellent correlation. Thus, at least in these late stages, ltk expression in NC derivatives is restricted to iridophores.

Initial ltk expression in a subset of NCCs was seen near the eye at 18–24 hpf (Figure 3A–3C). Between 26 and 30 hpf, these cells spread over the pigmented retinal epithelium from the dorsal surface of the eye (Figure 3F, 3K, and 3Q). This widespread scattered distribution was then maintained, but the density in a ring around the lens increased (data not shown), consistent with the WT pattern of corneal iridophores (Figure 1A). Plastic sections showed cells on the eye were superficial to the pigmented retinal epithelium (Figure 3W), consistent with a NC origin.

Expression of ltk in trunk and tail NC at early stages was very dynamic, with transient expression in a subset of premigratory NC spreading progressively more posteriorly between 18 and 28 hpf (Figure 3A–3C, 3H, and 3M). These premigratory NCCs were bilaterally arranged dorsolateral to the neural tube (Figure 3D). From 26 hpf onwards, a few ltk-expressing cells were migrating on the medial, but never the lateral, migration pathway, as expected for iridoblasts (Figure 3H, 3M, and 3S). As early as 30 hpf, the pattern of strongly ltk-expressing cells in whole mount embryos and confirmed in plastic sections closely mimiced that later seen for iridophores (Figure 3S and 3X). For example, in the dorsal stripe, cells were medially positioned and somewhat regularly spaced along the posterior trunk and tail. Hence, we interpreted these cells as iridoblasts and suggest that ltk-expression marks the iridophore lineage throughout their development. However, NC expression of ltk is seen very early in a subset of premigratory NCCs, which may include a subset of multipotent NCCs.

shd mutants lack iridophore markers

shdty82 mutants usually showed no iridophores and hence a primary role for ltk in iridoblast proliferation was unlikely, since this would predict only a reduction in iridophores. Using phosphohistone H3 as a marker for proliferating cells, we were unable to detect a significant effect on NCC proliferation (Figure S4).

To address a role in iridophore differentiation, we examined both known iridoblast markers, ednrb1 and ltk, reasoning that if ltk function was required only for iridophore differentiation these early markers would still be expressed normally in shd mutants. However, no ednrb1- or ltk-expressing cells were seen in shdty82 mutants at 50–72 hpf (Figure 3P, 3V, 3AB, and 3AF) and only reduced numbers in the weaker shdty9 mutants (data not shown). We were unable to use ednrb1 as an iridophore marker at earlier stages since it is expressed in cells of multiple pigment cell lineages prior to 48 hpf. Instead, we examined ltk expression in earlier embryos. At these stages shdty82 mutants could not be directly distinguished, but, from c. 20 hpf onwards, the expected 25% of embryos showed a consistent phenotype of severely reduced numbers of ltk-expressing cells. That these were shdty82 homozygotes was confirmed by RFLP genotyping of 20–24 hpf embryos prior to whole-mount in situ analysis; all homozygous WTs (n = 68) showed normal ltk expression (Figure 3B, 3C, 3H, 3M, 3S, 3Y, and 3AC; data not shown), wheareas all shdty82 homozygotes (n = 67) showed the reduced pattern (Figure 3I, 3N, 3T, 3Z, and 3AD; data not shown). Mutants consistently showed three main features: i) ltk-expressing cells failed to spread across the eye and remained low in number (Figure 3G, 3L, and 3R); ii) strong ltk expression was absent, with expression restricted to at most a few faintly expressing cells (Figure 3I, 3N, and 3T), except iii) from 35 hpf, a variable but always greatly reduced number of strongly expressing ‘escaper’ cells in the anterior trunk ventral stripe (i.e. residual lateral patch cell clusters)(data not shown). In summary, throughout the stages when NCCs in WTs are specified to individual fates and begin to differentiate, shdty82 mutants showed a consistent phenotype of highly reduced numbers of ltk-positive cells, with ‘escaper’ cells with normal ltk expression restricted to a few cells on the dorsal eye and in the residual lateral patches. Both the presence of these escaper cells and the similar strong reduction in numbers of ltk-expressing cells in ltk morphants (JM and RNK, data not shown) argue against the possibility that absence of ltk-expressing neural crest cells reflects nonsense-mediated decay of ltk transcripts in this mutant. Thus, specification of almost all iridoblasts fails in shdty82 mutant embryos.

shd mutants do not show precocious melanoblast or xanthoblast specification

We then investigated the fate of NCCs that failed to become specified as iridoblasts. In mitfa/nacre mutants, melanophore fate specification fails and increased iridophore numbers are seen, perhaps due to multipotent melanophore precursors adopting an iridophore fate in elevated numbers (Lister et al. 1999). Hence we considered whether some shd mutant iridoblast precursors might adopt another pigment cell fate. The late melanophore pattern in shdty82 mutants is overtly normal (see Figure S1C, S1D, S1E, and S1H), and counts of melanophores in the dorsal stripe of 3 dpf shdty82 mutants (mean±s.d. = 87.4±2.06, n = 33) and their WT siblings (82.4±2.19, n = 31) showed no significant difference (Student's t-test, p = 0.100)(Figure 4B). We then considered the possibility that an overproduction of melanoblasts or xanthoblasts at early stages might later be compensated by regulative processes. Hence, we asked whether shdty82 homozygotes showed elevated melanoblast or xanthoblast numbers at 30 hpf compared with homozygous WT siblings (Figure 4C and 4D). Embryos were genotyped prior to mRNA whole mount ISH for, respectively, dopachrome tautomerase (dct; or guanine cyclohydrolase (gch;. Whilst dct is expressed exclusively in the melanophore lineage, gch expression, like other characterised xanthophore markers, is seen transiently in the melanophore lineage, as well as being strongly upregulated in xanthophore lineage cells. In order to ensure that our counts focused as much as possible on the xanthophore lineage, we confined our attention to gch-expressing cells on the lateral pathway, since xanthoblasts do not utilise the medial pathway. Counts of dct-positive melanoblasts in shdty82 homozygotes (128.0±3.77, n = 35) and homozygous WT siblings (125.3±3.42, n = 39) were statistically indistinguishable (Student's t-test, p = 0.598). Similarly, counts of gch-positive xanthoblasts in shdty82 homozygotes (97.8±5.65, n = 23) and homozygous WT siblings (90.5±4.50, n = 23) were indistinguishable (Student t-test, p = 0.315). Thus we found no evidence for a shift of iridoblast precursors to either a melanophore or xanthophore fate.

shd mutants show elevated NCC death

In sox10 mutants, neural and pigment cell precursors that fail to become fate-specified are later (35–45 hpf) lost by apoptosis. We explored whether any NCCs in shdty82 mutants were lost by apoptosis. We generated shdty82 fish carrying the 7.2sox10∶gfp transgenic line (J.R. Dutton and R.N.K., in prep.), in which a 7.2 kb fragment of the zebrafish sox10 promoter drives expression of GFP, robustly labelling all NCCs. We combined the TUNEL technique with immunofluorescent detection of GFP on 35–50 hpf embryos from crosses of shdty82 heterozygotes carrying this transgene, scoring TUNEL+/GFP+ NCCs in each embryo at a single time-point. Most embryos showed none, but approximately 25% (20/89) showed one double-labelled cell, consistent with the idea that NCC death was a feature of shd homozygotes. To test directly the hypothesis that NCC death was characteristic of shd mutants, we counted dying NCCs in the trunk and tail of live embryos from such crosses. Approximately 25% of embryos showed up to 2 cells with an apoptotic morphology in either premigratory or medial pathway GFP+ NCCs at 30–50 hpf. We sorted such fish and genotyped them by iridophore phenotype at 3 dpf (Figure 4A). This data confirmed that apoptosis of NCCs was significantly elevated (Student's t test, p<0.0001) in shdty82 homozygotes (mean±s.d. = 0.41±0.125, n = 22) compared with their WT siblings (0.02±0.016, n = 61). Although the number of dying cells recorded in any individual embryo was low, we note that embryos were only examined once. Given that apoptotic morphology is a very transient characteristic (RNK, unpub. obs.), our observations indicate that a significant number of NCCs that failed to become iridoblasts were most likely lost by apoptosis in shd mutants.

ltk expression in sox10 mutants reveals NCCs trapped in an intermediate phase of NC or iridoblast development

In sox10t3 mutants iridophores are almost invariably absent, whereas in sox10m618 occasional, normally differentiated escaper iridophores are seen in the dorsal and ventral stripes; the iridophore phenotype is thus directly comparable with that of shdty82 mutants (Figure 5A and 5B). Furthermore, our previous studies of the sox10 mutant neural crest phenotype showed several features shared with the shd phenotype, specifically the absence of fate-switching and late death of neural crest cells. Given the general failure of fate-specification of non-ectomesenchymal derivatives in sox10 mutant fish and mice,,,,,,,,,,,, we expected iridoblast specification markers to be absent from the earliest stages in sox10t3 mutants. Hence, we examined ltk expression in sox10t3 mutants and their WT siblings (Figure 5C–5H). Unlike WTs, but just like in shdty82 mutants, sox10t3 mutants almost entirely lacked ltk expression on the eye and in the dorsal, ventral and yolk sac stripes at 48 hpf, although a few escaper cells were seen in the anterior trunk ventral stripe (Figure 5G and 5H), as expected since unspecified pigment cell precursors undergo apoptosis. In contrast, a striking, but unexpected, ltk phenotype was seen at earlier stages in these mutants. In WT siblings at 24 and 30 hpf, ltk expressing cells are seen in the trunk and tail in premigratory NCCs, on migration, in the ventral stripe or clustered behind the otic vesicle (Figure 5C and 5E). In contrast, in sox10t3 mutants, ltk-expressing cells were increased in number compared with WT siblings, and were restricted to premigratory NC (Figure 5D and 5F).

Our previous single NCC labelling studies showed that a large proportion of NCCs in sox10 mutants fail to migrate, a defect also detected by whole-mount ISH for sox10. We asked whether these sox10 mutant NCCs might be trapped in an early NCC state, but two very early NC markers, snail2 and foxd3,, showed identical expression in sox10t3 mutants and their WT siblings (Figure 6A–6H). In addition, cells expressing these early NC markers were located more posteriorly than the ltk-expressing cells in both sox10 mutants and WT siblings (Figure 6E–6J). We conclude that ltk is not expressed in the developmentally youngest NCCs, but only in those at a slightly more mature stage.

Early sox10 expression is widespread in NCCs. Furthermore, sox10 expression is associated with multipotency of NC stem cells. We asked whether ltk-expressing cells in sox10 mutants showed sox10 expression (Figure 7). For these experiments we used sox10m618 embryos, which also show NCCs trapped in a premigratory position, since sox10 transcripts are apparently destabilised in sox10t3 mutant embryos. Interestingly, many of these sox10-expressing cells showed ltk-expression at 30 hpf (Figure 7C and 7D). In contrast, WT siblings had largely mutually exclusive sox10 and ltk expression, suggesting that ltk-expressing cells were specified iridoblasts by this stage in WT embryos (Figure 7A and 7B). Together these data show that ltk expression comes on in NCCs after the early premigratory NC markers snail2 and foxd3, and that it labels cells that have developed beyond the initial premigratory NCC state, but which may retain multipotency.

Discussion

We present a combination of genetic mapping, morpholino-mediated knockdown, and molecular lesion data that unambiguously identifies the shd locus as encoding zebrafish ltk. In mammals, ALK and LTK are distinguished by the presence or absence respectively of MAM domains. However, our phylogenetic analysis shows that presence of MAM domains is the ancestral condition in the ALK/LTK subfamily. Their loss is unique to mammalian Ltks, and not generally diagnostic of the LTK family. Our phylogenetic analysis also suggests that vertebrate Alk and Ltk arose by a gene duplication event early in the vertebrate lineage and are thus co-orthologues of the Drosophila Alk and C. elegans T10H9.2 genes.

The functions of this subfamily of RTKs remain poorly understood. Human LTK is expressed in pre-B lymphocytes and various other tissues, but its endogenous function remains entirely unknown. In Drosophila, Alk signalling specifies visceral muscle pioneers, and regulates axonal guidance and in C. elegans it functions in synapse differentiation. Mouse Ltk knockouts have not been described. Thus we identify the first vertebrate model for studying ltk gene function.

We demonstrate a key role for ltk in NC-derived pigment cell development. We see initial low level ltk expression in a subset of premigratory NCCs followed by persistent robust expression in the iridophore lineage. Furthermore, iridophore lineage markers are absent from shd/ltk mutants, suggesting a very early role in iridophore development, most likely fate specification of iridoblasts from multipotent neural crest cells. Previously, there has been no data concerning the timing when iridophore fate specification occurs, although an informative comparison can be made with melanophore development for which fate specification can be defined precisely as the time when mitfa is first expressed. The timing of this varies along the antero-posterior axis, but at approximately 21 hpf has just begun in the posterior trunk. Two other very early markers of melanoblasts, dct and kit, also begin to be expressed in this region from approximately 21 hpf,,. Thus, in the case of the melanophore, specification begins in the posterior trunk approximately 21 hpf and this is also reflected by expression of two other very early melanoblast marker genes. We show that ltk is already expressed more broadly, throughout the posterior trunk, at this stage. In an mitfa mutant, defects in melanoblasts are seen from 23 hpf at least; in contrast, defects in melanoblast markers in strong mutants for the kit gene, an RTK important for melanoblast survival, are absent at 24 hpf, but detectable at 36 hpf. In addition, the severity of the shdty82 mutant phenotype, with iridophores totally absent, fits well with the mitfa mutant phenotype, but contrasts with that of the survival mutant, kit. Thus, using the best analogy available, the nature and timing of the defects in shd/ltk mutants, being already visible at 20 hpf, best reflects a defect in iridoblast specification. Previous identification of numerous mutants affecting iridophore development shows many in which iridophore differentiation is clearly abnormal, with cells looking duller or whiter than in WT siblings. Hence, the normal differentiation of any ‘escaper’ iridophores, even in shdty82 homozygotes, strongly argues against a later role for Ltk in iridophore differentiation. Maintenance of ltk expression in premigratory NCCs is dependent upon Ltk function since in shd, but not sox10 mutants, ltk expression was absent from iridophore precursors prior to their death. We saw no evidence for fate-switching between different pigment cell fates and although shd mutants show elevated NCC death, this is clearly a secondary effect since it occurs well after (c. 35–50 hpf) the initial fate specification phenotype. These two features are strongly reminiscent of our previous characterisation of the sox10 mutant phenotype and suggest important parallels between the cell-biological defects in sox10 and shd/ltk mutants.

Our ltk expression data is most immediately interpreted as suggesting that ltk is expressed from a very early point in iridophore specification, but is restricted to the iridophore lineage. However, the very early low level expression pattern in rows of premigratory cells, could also be interpreted as suggesting a transient early phase of expression in multipotent neural crest cells, before being upregulated and maintained in those cells that become specified to an iridophore fate. Our sox10 mutant data, whilst initially unexpected, supports the hypothesis that ltk is expressed initially in a subset of multipotent neural crest cells. Zebrafish sox10 mutants have reductions in non-ectomesenchymal NC derivatives, including melanophores and iridophores. Detailed investigation of melanocyte defects in sox10 mutants showed definitively that Sox10 regulation of mitfa transcription, and thus melanocyte fate specification, was the primary defect. A direct test of whether a similar mechanism applies to iridophores will require the identification of ‘master regulator’ transcription factor(s) for this cell-type. However, our analysis of sensory and enteric neuron defects in sox10 mutant zebrafish, together with studies of glia, sympathetic neurons and melanocytes in Sox10 mutant mice identify a common theme of failure of fate specification from multipotent precursors resulting from impaired transcription of ‘master regulator’ transcription factors,,,,,,,,,,,. In this context, under the assumption that ltk expression was the earliest known marker for the iridoblast lineage and that ltk expression simply marked iridophore specification, we predicted that sox10 mutants would not show ltk expression at all. Consequently, we were initially surprised to find a prominent accumulation of ltk-expressing neural crest cells. The overabundance of these ltk-expressing cells in sox10 mutants, tightly clustered in a premigratory position, suggested that these cells were early NCCs. However, they did not express the early NCC markers, snail2 and foxd3, and were found only more anteriorly (i.e. in developmentally older cells), suggesting that they were a distinct population of partially-restricted progenitors, consistent with the progressive fate restriction model. These cells do express sox10, a gene required for maintenance of multipotency in at least neural precursors,. We propose that in WT embryos ltk is expressed transiently in multipotent NCCs, but that in sox10 mutants, where fate specification is prevented, these cells remain trapped in this partially restricted progenitor state (Figure 8). The alternative interpretation of our data, that ltk expression is restricted to, and indeed defines, specified iridoblasts would lead to the conclusion that iridoblast fate specification occurs in sox10 mutants, but that further development fails. Whilst plausible, we do not favour this model because our data is fully consistent with the specification model shown to have general applicability to all other fates examined to date. Furthermore, we have previously shown that crestin, a general and early marker of differentiated lineages, is not expressed in these cells in sox10 mutants. Since in sox10 mutants all pigment cell precursors fail to migrate, whereas neural precursors migrate normally, we speculate that the ltk-expressing cells may be multipotent pigment cell progenitors,. A definitive test of our proposals will require development of zebrafish neural crest cell culture or of tools to definitively fate map ltk-expressing cells.

Our data identifies a novel RTK pathway mediating NC development. RTKs have diverse roles in development, including in fate specification. Indeed, Drosophila Alk functions in specification of visceral muscle pioneers,. However, in pigment cell development RTK function has been shown to be important for proliferation, survival and migration, but not fate specification,, –. For example, zebrafish kit mutants show a partial reduction in melanoblast numbers from approximately 36 hpf, and fms mutants show a failure of xanthoblast migration approximately 28 hpf. In contrast, shdty82 mutants show a phenotype that is both earlier and much more severe than in these other RTK mutants. Indeed, our data reveal that iridophore fate specification occurs very early, with timing equivalent to that of melanocyte fate specification, despite the later differentiation of iridophores (c. 42 hpf for iridophores, c. 25 hpf for melanophores).

We show that in zebrafish Ltk is crucial for specification of a particular pigment cell type, the iridophore, from NCCs. Our data contributes to understanding how pigment cell fate specification from these multipotent cells occurs. The challenge for the future will be to identify the genetic interactions between ltk, sox10 and other genes determining pigment cell fate choice. The ubiquitous nature of iridophores in fish, amphibians and reptiles suggests that Ltk function in NC is likely to be widespread. At least some birds, including doves, show iridophore-like cells in their iris, but their embryological origin is unclear, so examination of Ltk expression in appropriate avian embryos will be revealing. Iridophores have been lost in mammals, yet Ltk has been evolutionarily conserved. Strong shd mutant alleles are homozygous lethal, but this lethality cannot be attributed to the iridophore phenotype, and perhaps results from conserved functions in brain. Further characterisation of defects in shd mutants will allow identification of any conserved roles. Finally, our data suggest simple, visual in vivo screens for LTK inhibitors which may be of utility considering the growing links of these RTKs to autoimmune disease,.

Fish strains

shd ty82, shd ty9 and shdty70 have been described. shdj9s1 was identified as a spontaneous mutation in AB stocks, and shdj9e1 in an early pressure screen for adult phenotypes. shdj9e2 was identified in a non-complementation screen with shdj9s1. WIK11 WT was used to generate the reference mapping crosses. WT cDNA was amplified from the AB line. All studies conformed to local and UK national ethical guidelines.

Microscopy

Embryos were imaged on an Eclipse E800 (Nikon) using a U-III or DS-U1 camera (Nikon) or an LSM Meta confocal (Zeiss) microscope.

Whole-mount ISH

Embryos were processed as previously.

Immunofluorescent studies

Embryos for antibody staining were processed as previously described. Antibodies used: mouse anti-Hu C/D (Molecular Probes); rabbit anti-phospho-Histone H3 (Upstate Biotechnology, Cat#06-570); mouse anti-GFP, goat anti-mouse Alexa488 and anti-rabbit Alexa546 (Molecular Probes). TUNEL assays were carried out using an ApopTag® Peroxidase In Situ Apoptosis Detection Kit (Chemicon, Cat#:S7100) according to manufacturer's instructions.

Cell transplantation

Assessment of cell-autonomy was performed as described before. Labelled cells were detected by rhodamine fluorescence in the live embryo and by peroxidase detection of biotinylated tracer in embryos fixed after photographing the iridophore pattern.

Mapping and PAC library screen

Heterozygous F1 fish from the mapping cross were incrossed and separate pools of F2 homozygous shd mutants and their WT siblings were used for simple sequence length polymorphism analysis. Linkages from the pools were confirmed and refined by genotyping 1000 individual mutant embryos. The PAC 706 genomic library (RZPD) was screened with the marker z10985 by PCR; three positive PAC clones, BUSMP706P14181Q2 (PAC1), BUSMP706N10265Q2 (PAC2) and BUSMP706O16107Q2 (PAC3), were provided by RZPD.

Phenotypic rescue

450 pg of PAC DNA was injected in 2-cell stage embryos from shdty82/+ carrier cross. Morpholino antisense oligonucleotides (Gene Tools) were injected into fertilized WT eggs at the one-cell stage, at concentrations up to 35 ng per embryo and incubated at 28.5°C until 72 hpf. ltk morpholino sequence, 5′-agtttgtcgagtaatataatccat-3′; mismatch control, 5′-actttctccagtaatattatgcatg-3′.

Sequencing and gene identification

Three PACs containing z10985 were sequenced by the Danio rerio Sequencing Project at the Wellcome Trust Sanger Institute (Sequences of PACs 1–3 have accession numbers BUSM1-181P14, BUSM1-265N10 and BUSM1-107O16 respectively and can be accessed from http://www.sanger.ac.uk/Projects/D_rerio/). Predicted genes were identified using Nucleotide Identify X (NIX) software (UK Human Genome Mapping Project Resource Centre).

Mutation identification

WT cDNAs were isolated using SMART RACE PCR (Clontech) and long PCR using the Herculase enhanced DNA polymerase (Stratagene), cloned in Zero Blunt TOPO (Invitrogen) and sequenced commercially (Oswel). ltk cDNAs were amplified from shdty82 and shdj9e2 embryos and sequenced directly. RFLP analysis of shdty82 and siblings was performed on PCR fragments amplified from genomic DNA prepared from single embryos. Sequences were aligned using ClustalW multiple sequence alignment software. WT and mutant cDNA sequences have been deposited in Genbank under accession numbers 1051419 and 1057253 respectively.

Embryonic genotyping

Individual embryos, or heads of individual embryos if embryos were to be subsequently processed for in situ hybridisation, were placed in 96-well plates, washed three times with PBS, digested at 55°C in 2 mg/ml Proteinase K (Roche) for 4 hours, then heated at 95°C for 10 min to inactivate enzyme. Diagnostic PCR was performed using forward (5′-CTAACTCAAAGCAGTTTCGT-3′) and reverse (5′-GTAACGTCATGAGCAGATAA-3′) primers and the following PCR programme: 3 mins at 94°C; 35 cycles of 30 sec at 94°C, 30 sec touchdown from 55–47°C, 30 s at 72°C; 10 mins at 72°C. PCR products were then cut with NheI and run on agarose gel to reveal diagnostic bands: 420 bp (WT), 360 and 130 bp (shdty82).

Phylogenetic analysis

The cloned sequences were compared with homologous sequences in a phylogenetic analysis using a Bayesian method implemented in MrBayes (v3.1.2) and a maximum likelihood analysis implemented in TREEFINDER applied to each of four alignments. See Table S2 and Figure S3.

Diagnosis of protein subdomains utilised interpro (http://www.ebi.ac.uk/interpro/).

References 64

  1. 1.

    Le Douarin NM, Kalcheim C. The Neural Crest. 1999.

    Not in our library

  2. 2.

    Sommer L. Growth factors regulating neural crest cell fate decisions. Adv Exp Med Biol. 2006;589:197-205.

    Not in our library10.1007/978-0-387-46954-6_12 (opens in a new tab)

  3. 3.

    Le Douarin NM, Dupin E. Multipotentiality of the neural crest. Curr Opin Genet Dev. 2003;13:529-536.

    Not in our library10.1016/j.gde.2003.08.002 (opens in a new tab)

  4. 4.

    Weston JA. Sequential Segregation and Fate of Developmentally Restricted Intermediate Cell Populations in the Neural Crest Lineage. Curr Topics Dev Biol. 1991;25:133-153.

    Not in our library10.1016/s0070-2153(08)60414-7 (opens in a new tab)

  5. 5.

    Lister JA, Robertson CP, Lepage T, Johnson SL, Raible DW. nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate. Development. 1999;126:3757-3767.

    Not in our library10.1242/dev.126.17.3757 (opens in a new tab)

  6. 6.

    Opdecamp K, Nakayama A, Nguyen MTT, Hodgkinson CA, Pavan WJ, et al. Melanocyte development in vivo and in neural crest cell cultures: Crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription. Development. 1997;124:2377-2386.

    Not in our library10.1242/dev.124.12.2377 (opens in a new tab)

  7. 7.

    Steingrimsson E, Moore KJ, Lamoreux ML, Ferre-D'Amare AR, Burley SK, et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet. 1994;8:256-263.

    Not in our library10.1038/ng1194-256 (opens in a new tab)

  8. 8.

    Bondurand N, Pingault V, Goerich DE, Lemort N, Sock E, et al. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet. 2000;9:1907-1917.

    Not in our library10.1093/hmg/9.13.1907 (opens in a new tab)

  9. 9.

    Elworthy S, Lister JA, Carney TJ, Raible DW, Kelsh RN. Transcriptional regulation of mitfa accounts for the sox10 requirement in zebrafish melanophore development. Development. 2003;130:2809-2818.

    Not in our library10.1242/dev.00461 (opens in a new tab)

  10. 10.

    Lee M, Goodall J, Verastegui C, Ballotti R, Goding CR. Direct regulation of the microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J Biol Chem. 2000;275:37978-37983.

    Not in our library10.1074/jbc.m003816200 (opens in a new tab)

  11. 11.

    Potterf SB, Furumura M, Dunn KJ, Arnheiter H, Pavan WJ. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet. 2000;107:1-6.

    Not in our library10.1007/s004390000328 (opens in a new tab)

  12. 12.

    Verastegui C, Bille K, Ortonne JP, Ballotti R. Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J Biol Chem. 2000;275:30757-30760.

    Not in our library10.1074/jbc.c000445200 (opens in a new tab)

  13. 13.

    Kelsh RN. Sorting out Sox10 functions in neural crest development. Bioessays. 2006;28:788-798.

    Not in our library10.1002/bies.20445 (opens in a new tab)

  14. 14.

    Girard M, Goossens M. Sumoylation of the SOX10 transcription factor regulates its transcriptional activity. FEBS Lett. 2006;580:1635-1641.

    Not in our library10.1016/j.febslet.2006.02.011 (opens in a new tab)

  15. 15.

    Dorsky RI, Raible DW, Moon RT. Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev. 2000;14:158-162.

    Not in our library

  16. 16.

    Takeda K, Yasumoto K, Takada R, Takada S, Watanabe K, et al. Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J Biol Chem. 2000;275:14013-14016.

    Not in our library10.1074/jbc.c000113200 (opens in a new tab)

  17. 17.

    Yasumoto K, Takeda K, Saito H, Watanabe K, Takahashi K, et al. Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. Embo J. 2002;21:2703-2714.

    Not in our library10.1093/emboj/21.11.2703 (opens in a new tab)

  18. 18.

    Ben-Neriah Y, Bauskin AR. Leukocytes express a novel gene encoding a putative transmembrane protein-kinase devoid of an extracellular domain. Nature. 1988;333:672-676.

    Not in our library10.1038/333672a0 (opens in a new tab)

  19. 19.

    Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, et al. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene. 1997;14:2175-2188.

    Not in our library10.1038/sj.onc.1201062 (opens in a new tab)

  20. 20.

    Bernards A, de la Monte SM. The ltk receptor tyrosine kinase is expressed in pre-B lymphocytes and cerebral neurons and uses a non-AUG translational initiator. Embo J. 1990;9:2279-2287.

    Not in our library10.1002/j.1460-2075.1990.tb07399.x (opens in a new tab)

  21. 21.

    Maru Y, Hirai H, Takaku F. Human ltk: gene structure and preferential expression in human leukemic cells. Oncogene Res. 1990;5:199-204.

    Not in our library

  22. 22.

    Li N, Nakamura K, Jiang Y, Tsurui H, Matsuoka S, et al. Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus. Hum Mol Genet. 2004;13:171-179.

    Not in our library10.1093/hmg/ddh020 (opens in a new tab)

  23. 23.

    Kelsh RN, Brand M, Jiang YJ, Heisenberg CP, Lin S, et al. Zebrafish pigmentation mutations and the processes of neural crest development. Development. 1996;123:369-389.

    Not in our library10.1242/dev.123.1.369 (opens in a new tab)

  24. 24.

    Carney TJ, Dutton KA, Greenhill E, Delfino-Machin M, Dufourcq P, et al. A direct role for Sox10 in specification of neural crest-derived sensory neurons. Development. 2006;133:4619-4630.

    Not in our library10.1242/dev.02668 (opens in a new tab)

  25. 25.

    Elworthy S, Pinto JP, Pettifer A, Cancela ML, Kelsh RN. Phox2b function in the enteric nervous system is conserved in zebrafish and is sox10-dependent. Mech Dev. 2005;122:659-669.

    Not in our library10.1016/j.mod.2004.12.008 (opens in a new tab)

  26. 26.

    Dutton KA, Pauliny A, Lopes SS, Elworthy S, Carney TJ, et al. Zebrafish colourless encodes sox10 and specifies non-ectomesenchymal neural crest fates. Development. 2001;128:4113-4125.

    Not in our library10.1242/dev.128.21.4113 (opens in a new tab)

  27. 27.

    Kelsh RN, Eisen JS. The zebrafish colourless gene regulates development of non-ectomesenchymal neural crest derivatives. Development. 2000;127:515-525.

    Not in our library10.1242/dev.127.3.515 (opens in a new tab)

  28. 28.

    Johnson SL, Africa D, Walker C, Weston JA. Genetic control of adult pigment stripe development in zebrafish. Dev Biol. 1995;167:27-33.

    Not in our library10.1006/dbio.1995.1004 (opens in a new tab)

  29. 29.

    Kelsh RN. Genetics and evolution of pigment patterns in fish. Pigment Cell Res. 2004;17:326-336.

    Not in our library10.1111/j.1600-0749.2004.00174.x (opens in a new tab)

  30. 30.

    Amemiya CT, Zhong TP, Silverman GA, Fishman MC, Zon LI, Detrich HW, Westerfield M, Zon LI. Zebrafish YAC, BAC, and PAC genomic libraries. The zebrafish: Genetics and genomics. 1999;235-258.

    Not in our library10.1016/s0091-679x(08)61904-4 (opens in a new tab)

  31. 31.

    Zondag GC, Koningstein GM, Jiang YP, Sap J, Moolenaar WH, et al. Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa. A critical role for the novel extracellular MAM domain. J Biol Chem. 1995;270:14247-14250.

    Not in our library10.1074/jbc.270.24.14247 (opens in a new tab)

  32. 32.

    Hubbard SR, Wei L, Ellis L, Hendrickson WA. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature. 1994;372:746-754.

    Not in our library10.1038/372746a0 (opens in a new tab)

  33. 33.

    Loren CE, Englund C, Grabbe C, Hallberg B, Hunter T, et al. A crucial role for the Anaplastic lymphoma kinase receptor tyrosine kinase in gut development in Drosophila melanogaster. EMBO Rep. 2003;4:781-786.

    Not in our library10.1038/sj.embor.embor897 (opens in a new tab)

  34. 34.

    Parichy DM, Mellgren EM, Rawls JF, Lopes SS, Kelsh RN, et al. Mutational analysis of endothelin receptor b1 (rose) during neural crest and pigment pattern development in the zebrafish danio rerio. Dev Biol. 2000;227:294-306.

    Not in our library10.1006/dbio.2000.9899 (opens in a new tab)

  35. 35.

    Kelsh RN, Schmid B, Eisen JS. Genetic analysis of melanophore development in zebrafish embryos. Dev Biol. 2000;225:277-293.

    Not in our library10.1006/dbio.2000.9840 (opens in a new tab)

  36. 36.

    Parichy DM, Ransom DG, Paw B, Zon LI, Johnson SL. An orthologue of the kit-related gene fms is required for development of neural crest-derived xanthophores and a subpopulation of adult melanocytes in the zebrafish, Danio rerio. Development. 2000;127:3031-3044.

    Not in our library10.1242/dev.127.14.3031 (opens in a new tab)

  37. 37.

    Britsch S, Goerich DE, Riethmacher D, Peirano RI, Rossner M, et al. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 2001;15:66-78.

    Not in our library10.1101/gad.186601 (opens in a new tab)

  38. 38.

    Kelsh R, Dawson I, Akam M. An analysis of abdominal-B expression in the locust Schistocerca gregaria. Development. 1993;117:293-305.

    Not in our library10.1242/dev.117.1.293 (opens in a new tab)

  39. 39.

    Kim J, Lo L, Dormand E, Anderson DJ. SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron. 2003;38:17-31.

    Not in our library10.1016/s0896-6273(03)00163-6 (opens in a new tab)

  40. 40.

    Paratore C, Goerich DE, Suter U, Wegner M, Sommer L. Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development. 2001;128:3949-3961.

    Not in our library10.1242/dev.128.20.3949 (opens in a new tab)

All 64 references

Cited by papers we hold 4

Questions about this paper

We email you if it is retracted, withdrawn, corrected or flagged.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.